Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

GEVO PEER ANALYSIS

Gevo Inc — metric-by-metric comparison with peers and the industry median

GEVOGevo Inc

🇺🇸 USA · NASDAQ · Basic Materials · Specialty Chemicals

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Specialty Chemicals

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial Health
GEVOIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
GEVO-4.5%POLHO+417.7%KLKIM+3.7%POLTK-18.4%MRSHL+56.2%KMPUR+24.3%
Year-to-Date (YTD)
GEVO-26.0%POLHO+30.5%KLKIM-20.3%POLTK-44.4%MRSHL+38.1%KMPUR+13.4%
1-Year
Split-adjusted
GEVO-4.5%OEC-49.9%MATV+3.9%HDSN-22.7%MNTK-32.2%FF+19.9%
Year-to-Date (YTD)
GEVO-26.0%OEC+5.3%MATV-37.5%HDSN-6.0%MNTK-6.0%FF+49.1%

Key Metric Comparison

P/E

Lower is better
GEVO—POLHO—KLKIM12.83POLTK—MRSHL—KMPUR530.80Median 27.42

ROE

Higher is better
GEVO-7.4%POLHO-9.4%KLKIM15.9%POLTK-7.8%MRSHL-17.8%KMPUR0.5%Median 4.4%

Net Margin

Higher is better
GEVO-19.4%POLHO-23.2%KLKIM9.1%POLTK-2.3%MRSHL-4.4%KMPUR0.1%Median 3.5%

Revenue Growth

Higher is better
GEVO314.9%POLHO-19.2%KLKIM15.3%POLTK33.7%MRSHL-13.7%KMPUR-30.2%Median 1.2%

P/E

Lower is better
GEVO—OEC—MATV5.33HDSN19.26MNTK101.45FF—Median 27.42

ROE

Higher is better
GEVO-7.4%OEC-21.1%MATV17.0%HDSN5.9%MNTK0.8%FF-31.7%Median 4.4%

Net Margin

Higher is better
GEVO-19.4%OEC-5.0%MATV3.9%HDSN5.7%MNTK1.2%FF-47.5%Median 3.5%

Revenue Growth

Higher is better
GEVO314.9%OEC-3.4%MATV0.8%HDSN10.7%MNTK0.4%FF-45.6%Median 1.2%

All Metrics

Valuation
MetricGEVOPOLHOKLKIMPOLTKMRSHLKMPURInd. Median
P/E——12.83●——530.8027.42
P/B0.78●1.091.7257.6520.912.311.81
EV/EBITDA27.6316.284.69●192.1341.176.4012.24
P/S2.012.521.1718.725.420.62●1.63
Financial Health
MetricGEVOPOLHOKLKIMPOLTKMRSHLKMPURInd. Median
Current Ratio4.31●0.872.341.931.001.161.87
Debt/Equity38.0%14.6%4.6%●9.7%58.2%148.4%63.0%
NetDebt/EBITDA5.711.38-0.70●-0.030.572.282.15
Profitability
MetricGEVOPOLHOKLKIMPOLTKMRSHLKMPURInd. Median
Net Margin-19.4%-23.2%9.1%●-2.3%-4.4%0.1%3.5%
ROE-7.4%-9.4%15.9%●-7.8%-17.8%0.5%4.4%
ROA-5.1%-7.3%11.5%●-4.8%-4.9%0.1%2.0%
EBITDA Margin9.2%16.9%21.8%●9.7%13.3%15.1%14.7%
Growth + Dividend
MetricGEVOPOLHOKLKIMPOLTKMRSHLKMPURInd. Median
Rev. Growth314.9%●-19.2%15.3%33.7%-13.7%-30.2%1.2%
NI Growth——-19.2%———-4.8%
Div. Yield—0.0%1.8%●0.0%0.0%0.0%1.5%
Payout—0.0%23.6%0.0%0.0%0.0%9.1%
Valuation
MetricGEVOOECMATVHDSNMNTKFFInd. Median
P/E——5.33●19.26101.45—27.42
P/B0.78●0.820.861.150.851.451.81
EV/EBITDA27.639.147.39●9.449.22—12.24
P/S2.010.17●0.211.091.251.871.63
Financial Health
MetricGEVOOECMATVHDSNMNTKFFInd. Median
Current Ratio4.311.002.263.380.854.79●1.87
Debt/Equity38.0%267.1%232.7%2.2%●59.8%—63.0%
NetDebt/EBITDA5.716.905.28-0.51●3.41—2.15
Profitability
MetricGEVOOECMATVHDSNMNTKFFInd. Median
Net Margin-19.4%-5.0%3.9%5.7%●1.2%-47.5%3.5%
ROE-7.4%-21.1%17.0%●5.9%0.8%-31.7%4.4%
ROA-5.1%-4.6%3.7%4.6%●0.5%-25.7%2.0%
EBITDA Margin9.2%7.8%9.7%11.0%21.5%●-38.2%14.7%
Growth + Dividend
MetricGEVOOECMATVHDSNMNTKFFInd. Median
Rev. Growth314.9%●-3.4%0.8%10.7%0.4%-45.6%1.2%
NI Growth———-19.0%●-70.1%—-4.8%
Div. Yield—1.4%5.4%●——5.2%1.5%
Payout—-5.4%29.7%——-20.1%9.1%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on GEVO

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 8, 26. This content is for informational purposes only and is not investment advice.